$LLBO Cyrcadia is underway in a final, limited cli

$LLBO Cyrcadia is underway in a final, limited clinical trial and a 510k device classification to validate the fourth generation of the product. Cyrcadia technology is exclusively licensed for development, manufacturing and marketing worldwide from Lifeline Biotechnologies, Inc (OTC Market: LLBO) The company is preparing to apply for FDA Clearance and a Euro CE Mark to market in the European Union and Asia Pacific markets, with anticipation of launching its technology to market in 2016. Cisco Systems, Inc. is financially supporting the filming of a documentary by Ironbound Films called “Detected Movie” to be released about the evolution of Cyrcadia technology. Please visit http://www.DetectedMovie.com and Cyrcadia Health at http://www.cyrcadiahealth.com.